about
Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma.Emerging drugs for the treatment of metastatic renal cancer.Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma.Sunitinib for advanced renal cell cancer.Surgical Complications of Presurgical Systemic Therapy for Renal Cell Carcinoma: A Systematic Review
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Signal-transduction inhibitors in renal cell carcinoma.
@ast
Signal-transduction inhibitors in renal cell carcinoma.
@en
type
label
Signal-transduction inhibitors in renal cell carcinoma.
@ast
Signal-transduction inhibitors in renal cell carcinoma.
@en
prefLabel
Signal-transduction inhibitors in renal cell carcinoma.
@ast
Signal-transduction inhibitors in renal cell carcinoma.
@en
P2860
P1433
P1476
Signal-transduction inhibitors in renal cell carcinoma.
@en
P2093
Cora N Sternberg
Nicholas J Vogelzang
P2860
P304
P356
10.1111/J.1464-410X.2007.06833.X
P433
P577
2007-05-01T00:00:00Z